Citation:De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al 2006

From Cancer Guidelines Wiki

Citation


De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006 Mar 1;24(7):1057-63 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16505424.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?Associate Professor Michael Michael MBBS(Hons), BSc(Hons), MD, FRACPcompleted
What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?Dr Jeremy Ruben MBBCh (Hons), FCRadOnc (SA), FRANZCR, Mmed, MD (Monash)completed
What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?Dr Jeremy Ruben MBBCh (Hons), FCRadOnc (SA), FRANZCR, Mmed, MD (Monash)completed

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Lung cancer review page
  2. What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?
  3. What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?
  4. What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?